Press & Media

PlexBio Receives CE Mark for IntelliPlex™ Lung Cancer Panel

2018.10.31


PlexBio Co., Ltd, an emerging multi-national diagnostic company, announced today that it has received CE mark for its IntelliPlex™ Lung Cancer Panel, an in vitro molecular diagnostic assay intended for the qualitative identification of 36 DNA mutations in the KRAS, NRAS, PIK3CA, BRAF and EGFR genes as well as 19 gene rearrangements of the ALK, ROS1, RET, NTRK1 and MET genes from formalin-fixed paraffin-embedded (FFPE) tumor tissue from lung cancer patients. ...more

Denka Signs Distribution Agreements with PlexBio for the IntelliPlex™ Instrument System and Reagents

2018.8.8


PlexBio Co., Ltd, an emerging multi-national diagnostic company, has signed the Distribution Agreement with Denka Co., Ltd. for its IntelliPlex™ 1000 πCode Processor and PlexBio™ 100 Fluorescent Analyzer for use in the Japanese life science research market. ...more

TFDA Licenses for IntelliPlex™ KRAS and KRAS+

2018.8.6


Taipei, Taiwan – August 6, 2018 - PlexBio Co., Ltd, an emerging multi-national diagnostic company, has passed GMP inspection and received export licenses from the Taiwan FDA for its CE Marked IntelliPlex™ KRAS and IntelliPlex™ KRAS Mutation Plus Kits. ...more

University "G. D'Annunzio" of Chieti Presents Data on PlexBio Technology at MDX Conference

2018.5.24


PlexBio is pleased to recognize that Dr. Nicla Borrelli from the University "G. D'Annunzio", Chieti, Italy, will be presenting at 6th International Molecular Diagnostics Europe conference at Lisbon Portugal, from May 22-24, 2018 on results from studies using PlexBio’s IntelliPlex™ multiplexing technology. ...more

Euroclone Signs Distribution Agreements with PlexBio for the IntelliPlex™ Instrument System and Reagents

2018.5.8


PlexBio Co., Ltd, an emerging multi-national diagnostic company, has signed an agreement with Euroclone S.p.A. of Milan to be the exclusive distributor its IntelliPlex™ 1000 πCode Processor and PlexBio™ 100 Fluorescent Analyzer for use in the Italian life science research market. ...more

< 1 | 2 | 3 | 4 | >